BALTAS PHARMA OÜ
Date of report 23.01.2025
BALTAS PHARMA OÜ
start | end |
---|---|
19.08.2015 | 20.04.2020 |
21.04.2020 | - |
keywords
- meditsiiniseadmete hulgimüük
BALTAS PHARMA OÜ
Scores and ratings
Reputation score
Credit Score
Open the reports you want to print
Employees and salaries
BALTAS PHARMA OÜ
Employee taxes and performance analysisQuarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
---|---|---|---|---|
2024 IV | ...... | ...... | ...... | ...... |
2024 III | ...... | ...... | ...... | ...... |
2024 II | ...... | ...... | ...... | ...... |
2024 I | ...... | ...... | ...... | ...... |
2023 IV | ...... | ...... | ...... | ...... |
2023 III | ...... | ...... | ...... | ...... |
2023 II | ...... | ...... | ...... | ...... |
2023 I | ...... | ...... | ...... | ...... |
2022 IV | ...... | ...... | ...... | ...... |
2022 III | ...... | ...... | ...... | ...... |
2022 II | ...... | ...... | ...... | ...... |
2022 I | ...... | ...... | ...... | ...... |
2021 IV | ...... | ...... | ...... | ...... |
2021 III | ...... | ...... | ...... | ...... |
2021 II | ...... | ...... | ...... | ...... |
2021 I | ...... | ...... | ...... | ...... |
2020 IV | ...... | ...... | ...... | ...... |
2020 III | ...... | ...... | ...... | ...... |
2020 II | ...... | ...... | ...... | ...... |
2020 I | ...... | ...... | ...... | ...... |
2019 IV | ...... | ...... | ...... | ...... |
2019 III | ...... | ...... | ...... | ...... |
2019 II | ...... | ...... | ...... | ...... |
2019 I | ...... | ...... | ...... | ...... |
2018 IV | ...... | ...... | ...... | ...... |
2018 III | ...... | ...... | ...... | ...... |
2018 II | ...... | ...... | ...... | ...... |
2018 I | ...... | ...... | ...... | ...... |
2017 IV | ...... | ...... | ...... | ...... |
2017 III | ...... | ...... | ...... | ...... |
2017 II | ...... | ...... | ...... | ...... |
2017 I | ...... | ...... | ...... | ...... |
2016 IV | ...... | ...... | ...... | ...... |
2016 III | ...... | ...... | ...... | ...... |
2016 II | ...... | ...... | ...... | ...... |
2016 I | ...... | ...... | ...... | ...... |
2015 IV | ...... | ...... | ...... | ...... |
2015 III | ...... | ...... | ...... | ...... |
2015 II | ...... | ...... | ...... | ...... |
2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
BALTAS PHARMA OÜ
Decision-makersFormer decision-makers
......
Credit Score: Trustworthy
Reputation score: 2130
Date of birth: ......
Active relations 3
5 followers
BALTAS PHARMA OÜ
Former decision-makers......
Credit Score: Trustworthy
Reputation score: 6320
Date of birth: ......
Active relations 5
8 followers
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
2 followers
......
Credit Score: Trustworthy
Reputation score: 2630
Date of birth: ......
Active relations 1
3 followers
......
Credit Score: Trustworthy
Reputation score: 2640
Date of birth: ......
Active relations 2
1 follower
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
2 followers
BALTAS PHARMA OÜ
History of right of representationBALTAS PHARMA OÜ
OwnersFormer owners
Name | Credit Score | Payment | Beginning | Type | Holding |
---|---|---|---|---|---|
...... | ...... | ...... |
100%
|
Former owners
BALTAS PHARMA OÜ
Other related partiesFormer other persons
Beneficiaries
Volumes and values of beneficiaries' assets
Finances and assets
BALTAS PHARMA OÜ
GoodwillBALTAS PHARMA OÜ
Taxes paid and estimated average salariesBALTAS PHARMA OÜ
Quarterly indicatorsQuarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
---|---|---|---|---|---|---|---|
2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2018 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2017 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2016 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
2015 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
BALTAS PHARMA OÜ
Sales revenue by business areaBALTAS PHARMA OÜ
Sales revenue by countryBALTAS PHARMA OÜ
Financial indicators and prognosisBALTAS PHARMA OÜ
Financial raiting: "VERY GOOD" (2024 prognosis)BALTAS PHARMA OÜ
Annual reportsYear | Period | Submitted | Report PDF |
---|---|---|---|
2023 | 01.01.2023–31.12.2023 | 16.07.2024 | ...... |
2022 | 01.01.2022–31.12.2022 | 30.06.2023 | ...... |
2021 | 01.01.2021–31.12.2021 | 14.12.2022 | ...... |
2020 | 01.01.2020–31.12.2020 | 28.09.2021 | ...... |
2019 | 01.01.2019–31.12.2019 | 01.10.2020 | ...... |
2018 | 01.01.2018–31.12.2018 | 29.05.2020 | ...... |
2017 | 01.01.2017–31.12.2017 | 29.05.2020 | ...... |
2016 | 01.01.2016–31.12.2016 | 11.10.2017 | ...... |
2015 | 01.01.2015–31.12.2015 | 25.05.2016 | ...... |
Liabilities and debts
BALTAS PHARMA OÜ
Credit score history and prognosis... €
......
Business risk classes:
Trustworthy NeutralBALTAS PHARMA OÜ
Reports and assets-liabilities overview 23.01.2025BALTAS PHARMA OÜ
Claims historyTotal debt claims: ...... €
...... | ...... |
BALTAS PHARMA OÜ
Income (turnover) and expenditure (taxes paid)Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
---|---|---|---|---|---|
2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2018 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2017 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2016 I | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 III | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 II | * ...... € | ...... € | ...... € | ...... € | ...... |
2015 I | * ...... € | ...... € | ...... € | ...... € | ...... |
BALTAS PHARMA OÜ
Bailiff's enforcement proceedings as of 23.01.2025Bailiff's enforcement proceedings MISSING
BALTAS PHARMA OÜ
Regulations of the Payment Order Department as of 23.01.2025Regulations of the Payment Order Department MISSING
BALTAS PHARMA OÜ
Court orders in the register as of 23.01.2025Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata
Regulation number: Ä 50000471 / M6
Regulation status has entered into force: 17.07.2024
Date of enforcement of order or additional period: 10.07.2024
Regulation status: Puudused kõrvaldatud
Puuduste kõrvaldamise määrus
Regulation number: Ä 50000471 / M5
Regulation status has entered into force: 25.02.2020
Date of enforcement of order or additional period: 25.02.2020
Regulation status: Puudused kõrvaldatud
Puuduste kõrvaldamise määrus
Regulation number: Ä 50000471 / M4
Regulation status has entered into force: 25.02.2020
Date of enforcement of order or additional period: 19.02.2020
Regulation status: Puudused kõrvaldatud
BALTAS PHARMA OÜ
Decisions of the Consumer Disputes Committee as of 23.01.2025Consumer disputes MISSING
BALTAS PHARMA OÜ
Court hearings as of 23.01.2025Court hearings MISSING
BALTAS PHARMA OÜ
Rulings as of 23.01.2025Court settlemets MISSING
BALTAS PHARMA OÜ
Notices and announcements as of 23.01.2025Notice of delivery of a Tax and Customs Board document
Avaldamise lõpp: 19.04.2018
Menetlusosalisele Baltas Pharma OÜ (registrikood: 12779856) toimetatakse kätte 04.01.2018 korraldus nr 9-1.4/1177 2017. a novembrikuu maksudeklaratsiooni vorm TSD esitamiseks kümne päeva jooksul korralduse kättetoimetamisest arvates.
Korraldusega pandud kohustuse täitmata jätmisel on Maksu- ja Tolliametil õigus rakendada sunniraha, mille suurus on 100 eurot iga tähtaegselt esitamata deklaratsiooni kohta.
Dokumendi resolutiivosa loetakse kättetoimetatuks kümne päeva möödumisel käesoleva teadaande avaldamisest (MKS § 55).
Dokumentide terviktekstidega on võimalik tutvuda Maksu- ja Tolliameti lähimas teenindusbüroos.
Tallinn, HARJUMAA, Lõõtsa 8a
Telefon: 1811
E-post: emta@emta.ee
Marketing
Business network
BALTAS PHARMA OÜ
Business networkSign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
BALTAS PHARMA OÜ
Networks - BeneficiariesSign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.